Back to catalogue
TOO
Tooru PLC
310/1000 Overall fit
AI beneficiary 35% 20
Operating leverage 25% 40
Valuation 25% 35
Downside protection 15% 35
First-pass take
Wellness/nutrition acquisition with zero AI exposure; newly acquired operating units show positive H1 2024 EBITDA (£0.8m on £7.2m revenue) but face execution risk across four unproven units. Massive shareholder dilution and narrow cash runway to June 2026; no clear valuation multiples post-RTO.
Flags
rto-post-closeno-ai-exposureexecution-riskcash-runway-tightmicrocapshareholder-dilutionthin-forward-guidance